Grants and contracts awarded to Yale School of Medicine

Federal

• Karen Anderson, NIH, Molecular Mechansims in EGF Signaling and Iressa/Tarceva Inhibition in NSCLC, 5 years, $1,440,519
• Maile Brown, NIH, Genetic Regulation of K(Na) Channels in Neuronal Excitability, 3 years, $154,422
• Dario Englot, NIH, Neuroimaging, Energetics and Neuronal Activity in Spike-Wave Seizures, 3 years, $40,972
• Gerald Shadel, NIH, Epigenetic Regulation of Mitochondrial Complex II, 2 years, $574,992
• Gordon Shepherd, NIH, Integrative Mechanisms of Cortical Circuits, 3 years, $868,365
• Mark Shlomchik, NIH, Activation and Regulation of Autoreactive B Cells in Health and Disease, 5 years, $2,677,905
• Mary Torregrossa, NIH, Peptide Regulation of the Neurocircuitry Underlying Drug Relapse, 3 years, $49,646
• Benjamin Turk, NIH, Application of Peptide Arrays and Mass Spectrometry to Proteases, 3 years, $620,260
• Dianqing Wu, NIH, Therapeutic Targeting of Wnt Signaling, 5 years, $1,584,059

Non-Federal

• Clara Abraham, Crohn’s & Colitis Foundation of America Inc., LFA-1 and Regulatory T Cells, 1 year, $23,647
• Maysa Abu-Khalaf, Susan G. Komen Breast Cancer Foundation, An Integrated Approach to Biomarker Validation in Patients with HER-2 Positive Metastatic Breast Cancer Treated with Rapamycin (Rapamune) to Overcome Resistance to the HER-3 Targeted Therapy, Trastuzumab, 2 years, $300,000
• Dorothy Baker, State of Connecticut, Connecticut Fall Prevention Program, 18 months, $1,500,000
• Kathleen Connell, American Urogynecologic Society, Effect of HOXA11 Silencing in In Vitro and In Vivo Extracellular Matrix Remodeling, 2 years, $30,000
• Nihal deLanerolle, ORA Inc., DARPA Blast Injury (PRVENT), 1 year, $262,492
• Robert Dubrow, Pfizer Inc, Milestones in Public Health Grand Rounds Series: Health Disparities and the Challenge of the New Millennium, 1 year, $15,000
• David Geller, The Research Institute at Nationwide Children’s Hospital, Mechanisms of Glucocorticoid Action in Podocytes, 1 year, $9,446
• Michelle Harris, Arthritis Foundation, Interrogating Distal Checkpoints in Autoreactive Germinal Center Regulation, 3 years, $150,000
• Hajime Kanda, The Human Frontier Science Program Organization, Analysis of the Mechanism of Leptin Sensitivity in Immune Cells to Control Energy Balance In Vivo, 3 years, $145,900
• Patricia Keenan, The Pennsylvania State University, The Regional Quality Strategy Planning Grant, 6 months, $12,603
• Anthony Koleske, Elsa U. Pardee Foundation, Control of Breast Cancer Invasiveness by Adhesive Cues in the Tumor Microenvironment, 1 year, $122,233
• Dania Magri, American Vascular Association, The Role of EphB4 in Mediating VEGF-A Induced Vein Graft Adaptation, 1 year, $3,000
• Yuxin Mao, Lowe Syndrome Association, Structure Studies of the Lowe Syndrome Protein OCRL, 1 year, $20,000
• Michael Nathanson, American Gastroenterological Association, Development and Validation of a Multiphoton Endoscope for Surveillance Studies of Patients with Barrett’s Esophagus, 1 year, $10,000
• Kevin Nickerson, The S.L.E. Lupus Foundation, Inc., Opposing Roles of TLR7 and TLR9 Signaling in Systemic Lupus Erythematosus, 3 years, $135,000
• Edward Novotny, Children’s Hospital (Cincinnati), Childhood Absence Epilepsy (CAE): Evaluation and Predictors of Long-Term Outcome, 1 year, $54,573
• Rita Rienzo, Physician Assistant Education Association, Factors Influencing Graduate Physician Assistants in their Decision to Pursue Postgraduate Residencies, 1 year, $5,000
• Joanne Weidhaas, Radiation Therapy Oncology Group, Uterine Cancer and MicroRNAs, 1 year, $50,000
• Li Wen, Juvenile Diabetes Research Foundation International, Prevention and Treatment of T1D in Human CD20 Transgenic NOD Mice, 3 years, $495,000
• James Yue, Covidien, A Study to Evaluate the Performance of DuraSeal Xact Adhesion Barrier and Sealant System for the Prevention of Perivascular Adhesions in the Rabbit Artificial Disc Model, 1 year, $59,958